Companies/US/GERN

GERON CORPORATION

Last · NasdaqGS$1.22-0.005 (-0.41%)stale · yahoo · 55h ago
Vol 3.98M ≈ 4.86M
Market cap$783.82M642.5M sh
P/E · TTM-11.1fwd 30.5 · eps -0.11 · loss
Beta0.61vs S&P 500
Div yield0.00%annual · TTM
52w range
$1.04$2.01
Volume4.0Msession

Issuer

Legal nameGERON CORPORATION
HQUnited States (US)
ListingUS GERN
ISINUS3741631036
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0000886744
CIK0000886744
Employees258
AddressGeron Corp. 919 East Hillsdale Boulevard 94404, Foster City +650 473 7700
Headline financial metrics
Revenue$109.3M
Operating income$-12.3M
Net income$-20.3M
Operating margin-11.3%
Net margin-18.6%
Return on equity-9.3%
Period2026
Loading chart…

Upcoming earnings

1 event
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.01
Est. revenue
60.7M

Earnings transcripts

1 recent

Press & signals

3 of 6 recent
  • GlobeNewswire

    Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • GlobeNewswire

    Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • GlobeNewswire

    Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights

The rest of this company's wire — with summaries and source links — is part of Pro.

See plans

Documents

FormReporting forFiledFlags
2026-09-302026-10-010
2026-06-302026-08-05 5